Stimulatory effects of immune reactions upon the growths of untransplanted tumors.

Abstract:

:The accumulated literature suggests that altering the immune capacities of animals or humans seldom has detectable effects on tumor incidence nor, it seems, does the growth of an untransplanted tumor, either spontaneous or induced, immunize the host against the growth of a subsequent implant of that tumor. These observations suggest that even clearly immunogenic transplanted tumors may not have had their growths modulated by an immune reaction when they were as yet untransplanted in their primary hosts. Also, there are many data that have been interpreted to show that spontaneous tumors of rodents are, even when transplanted, nonimmunogenic. A reconsideration of the available studies, especially those in which either host immune capacity or tumor immunogenicity was titrated, has led me to different conclusions. I believe that the data suggest that probably all tumors, including spontaneous ones, are immunogenic but that the weak immune response in the primary host to the antigens of even the more immunogenic induced tumors usually produces stimulation of tumor growth rather than growth inhibition. The prevalence of immunogenicity suggests that vaccination or other forms of immunotherapy will eventually succeed; however, the analysis also suggests that, in the case of weakly immunogenic tumors, increasing the immune reaction, unless the increase is massive, may have little effect or may actually stimulate rather than inhibit the growths of these tumors in their primary hosts. Immunosuppression might actually be therapeutic in these cases; this may be an unrecognized benefit of the chemotherapy of many human tumors.

journal_name

Cancer Res

journal_title

Cancer research

authors

Prehn RT

subject

Has Abstract

pub_date

1994-02-15 00:00:00

pages

908-14

issue

4

eissn

0008-5472

issn

1538-7445

journal_volume

54

pub_type

杂志文章,评审
  • The HSP90 inhibitor ganetespib synergizes with the MET kinase inhibitor crizotinib in both crizotinib-sensitive and -resistant MET-driven tumor models.

    abstract::The proto-oncogene MET is aberrantly activated via overexpression or mutation in numerous cancers, making it a prime anticancer molecular target. However, the clinical success of MET-directed tyrosine kinase inhibitors (TKI) has been limited due, in part, to mutations in the MET kinase domain that confer therapeutic r...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-13-1156

    authors: Miyajima N,Tsutsumi S,Sourbier C,Beebe K,Mollapour M,Rivas C,Yoshida S,Trepel JB,Huang Y,Tatokoro M,Shinohara N,Nonomura K,Neckers L

    更新日期:2013-12-01 00:00:00

  • Neocarzinostatin-induced DNA strand scission and subsequent cell cycle traverse in HeLa S3 cells.

    abstract::HeLa cells were synchronized at the G1-S boundary by double thymidine block and treated for 1 hr with varying concentrations of the antibiotic anticancer protein neocarzinostatin (NCS). Cells were then released from the block and allowed to resume their cycle. Aliquots were removed at various times in order to monitor...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Berry DE,Collins JM

    更新日期:1980-07-01 00:00:00

  • Silencing of FLRG, an antagonist of activin, inhibits human breast tumor cell growth.

    abstract::Activin, a member of the transforming growth factor beta (TGFbeta) superfamily, regulates diverse processes, such as cellular growth and differentiation. There is increasing evidence that TGFbeta and its signaling effectors are key determinants of tumor cell behavior. Loss of sensitivity to TGFbeta-induced growth arre...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-0805

    authors: Razanajaona D,Joguet S,Ay AS,Treilleux I,Goddard-Léon S,Bartholin L,Rimokh R

    更新日期:2007-08-01 00:00:00

  • Noscapine, a benzylisoquinoline alkaloid, sensitizes leukemic cells to chemotherapeutic agents and cytokines by modulating the NF-kappaB signaling pathway.

    abstract::Noscapine, a benzylisoquinoline alkaloid derived from opium, was recently reported to exhibit activity against a variety of cancers through a poorly understood mechanism. Because the transcription factor NF-kappaB has been linked with inflammation, survival, proliferation, invasion, and angiogenesis in tumors, we hypo...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-4230

    authors: Sung B,Ahn KS,Aggarwal BB

    更新日期:2010-04-15 00:00:00

  • Transport and metabolism of 1-beta-D-arabinofuranosylcytosine in human ovarian adenocarcinoma cells.

    abstract::1-beta-D-Arabinofuranosylcytosine (araC) is an effective drug in the i.p. therapy of ovarian carcinoma but little is known of its transport and metabolism in this tumor. Influx of araC at 1 microM into cultured human ovarian carcinoma cells (CI 80-13S) was largely inhibited by nanomolar concentrations of the nucleosid...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Jamieson GP,Snook MB,Bradley TR,Bertoncello I,Wiley JS

    更新日期:1989-01-15 00:00:00

  • Effect of dietary cellulose on cell proliferation and progression of 1,2-dimethylhydrazine-induced colon carcinogenesis in rats.

    abstract::The effects of different levels of dietary cellulose on colonic crypt mitotic activity and colon carcinogenesis were studied in 190 male Sprague-Dawley rats. Rats were divided into groups and fed a basal fiber-free diet supplemented with either 0, 5, or 15% pure cellulose (w/w), for periods of 10 weeks (initiation sta...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Heitman DW,Ord VA,Hunter KE,Cameron IL

    更新日期:1989-10-15 00:00:00

  • Undermining Glutaminolysis Bolsters Chemotherapy While NRF2 Promotes Chemoresistance in KRAS-Driven Pancreatic Cancers.

    abstract::Pancreatic cancer is a disease with limited therapeutic options. Resistance to chemotherapies poses a significant clinical challenge for patients with pancreatic cancer and contributes to a high rate of recurrence. Oncogenic KRAS, a critical driver of pancreatic cancer, promotes metabolic reprogramming and upregulates...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-19-1363

    authors: Mukhopadhyay S,Goswami D,Adiseshaiah PP,Burgan W,Yi M,Guerin TM,Kozlov SV,Nissley DV,McCormick F

    更新日期:2020-04-15 00:00:00

  • Inflammation-mediated cytosine damage: a mechanistic link between inflammation and the epigenetic alterations in human cancers.

    abstract::Aberrant methylation patterns have long been known to exist in the promoter regions of key regulatory genes in the DNA of tumor cells. However, the mechanisms by which these methylation patterns become altered during the transformation of normal cells to tumor cells have remained elusive. We have recently shown in in ...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:10.1158/0008-5472.CAN-07-0846

    authors: Valinluck V,Sowers LC

    更新日期:2007-06-15 00:00:00

  • Intracellular expression of a single-chain antibody directed against human papillomavirus type 16 E7 oncoprotein achieves targeted antineoplastic effects.

    abstract::Human papillomavirus type 16 (HPV16) E7 is a viral oncoprotein that is believed to play a major role in cervical neoplasia. Anti-HPV16 E7 intracellular single-chain antibodies (scFvs) were constructed to down-regulate HPV16 E7 oncoprotein in HPV DNA-containing cell lines. In these studies, we transfected anti-E7 scFvs...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Wang-Johanning F,Gillespie GY,Grim J,Rancourt C,Alvarez RD,Siegal GP,Curiel DT

    更新日期:1998-05-01 00:00:00

  • Transforming growth factor beta induces apoptosis through repressing the phosphoinositide 3-kinase/AKT/survivin pathway in colon cancer cells.

    abstract::FET cells, derived from an early-stage colon carcinoma, are nontumorigenic in athymic mice. Stable transfection of a dominant-negative transforming growth factor beta (TGFbeta) type II receptor (DNRII) into FET cells that express autocrine TGFbeta shows loss of TGFbeta signaling and increased tumorigenicity in vivo in...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-5348

    authors: Wang J,Yang L,Yang J,Kuropatwinski K,Wang W,Liu XQ,Hauser J,Brattain MG

    更新日期:2008-05-01 00:00:00

  • Preparation of permanent slides of intact soft-agar colony cultures of hematopoietic and tumor stem cells.

    abstract::A simple technique is described for fixing colony-containing layers of soft agar and drying them onto microscopic slides. The method is extrapolated from techniques used in immunology for permanent preservation of immunodiffusion or immunoelectrophoresis plates. Slides prepared in this fashion are eminently suitable f...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Salmon SE,Buick RN

    更新日期:1979-03-01 00:00:00

  • Presence and instability of repetitive elements in sequences the altered expression of which characterizes risk for colonic cancer.

    abstract::50C10 and 52H10 are two DNA clones previously reported by us to be overexpressed in human colonic mucosa at high risk for development of colonic tumors. This report presents sequencing data that reveal that these clones contain repetitive Alu elements. Each Alu sequence is associated with a 3'-oligoadenylate [oligo(A)...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Chen J,Heerdt BG,Augenlicht LH

    更新日期:1995-01-01 00:00:00

  • c-myc amplification is a better prognostic factor than HER2/neu amplification in primary breast cancer.

    abstract::Amplification of the c-myc and HER2/neu genes was found in 20 and 23%, respectively, of primary breast cancer tissues derived from 282 patients (median follow-up, 74 months). c-myc amplification was observed more frequently in larger tumors (P = 0.01) and in lymph node-positive patients (P = 0.01) but was not associat...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Berns EM,Klijn JG,van Putten WL,van Staveren IL,Portengen H,Foekens JA

    更新日期:1992-03-01 00:00:00

  • Immunoassay of serum galactosyltransferase isoenzyme II in cancer patients and control subjects.

    abstract::Serum galactosyltransferase isoenzyme II (GT-II) was assayed in 409 coded serum samples obtained from the National Cancer Institute Tumor Serum Bank using a monoclonal antibody-based immunoassay. The serum panel consisted of samples from patients with confirmed, metastatic ovarian, breast, stomach, esophageal, pancrea...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Uemura M,Winant RC,Brandt AE

    更新日期:1988-09-15 00:00:00

  • Selective killing of methotrexate-resistant cells carrying amplified dihydrofolate reductase genes.

    abstract::A method for the selective killing of methotrexate (MTX)-resistant cells has been developed. The selection is based on the incorporation of tritiated deoxyuridine into the DNA of MTX-resistant cells but not normal MTX-sensitive cells in the presence of the drug. A Chinese hamster ovary cell mutant that overproduces di...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Urlaub G,Landzberg M,Chasin LA

    更新日期:1981-05-01 00:00:00

  • Inhibition of growth and proliferation of EcRG293 cell line expressing high-affinity gonadotropin-releasing hormone (GnRH) receptor under the control of an inducible promoter by GnRH agonist (D-Lys6)GnRH and antagonist (Antide).

    abstract::The mechanism by which gonadotropin-releasing hormone (GnRH) agonists and antagonists inhibit tumor cell growth and proliferation is controversial. Direct mediation of the antitumor effects through the high-affinity GnRH receptors has been questioned because of the low level of expression of receptors on the tumor cel...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Kakar SS

    更新日期:1998-10-15 00:00:00

  • Ultraviolet-specific mutations in p53 gene in skin tumors in xeroderma pigmentosum patients.

    abstract::Mutations in the p53 gene were identified in five of eight non-melanoma skin tumors in the sun-exposed areas of xeroderma pigmentosum patients by the polymerase chain reaction and single strand conformation polymorphism analysis followed by sequencing of the DNA. All mutations occurred at the dipyrimidine sites, indic...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Sato M,Nishigori C,Zghal M,Yagi T,Takebe H

    更新日期:1993-07-01 00:00:00

  • Formation and removal of (guan-8-yl)-DNA-2-acetylaminofluorene adducts in liver and kidney of male rats given dietary 2-acetylaminofluorene.

    abstract::Radioimmunoassay has been used to measure acetylated and deacetylated deoxyguanosine C-8 DNA adducts of 2-acetylaminofluorene in liver and kidney DNA of male Wistar-Furth rats fed a dietary regimen of 0.02 or 0.04% 2-acetylaminofluorene. When adduct formation was monitored during continuous feeding up to 60 days, subs...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Poirier MC,True B,Laishes BA

    更新日期:1982-04-01 00:00:00

  • Steroid sulfatase expression is an independent predictor of recurrence in human breast cancer.

    abstract::Steroid sulfatase (STS) hydrolyzes several sulfated steroids such as estrone sulfate, dehydroepiandrosterone sulfate, and cholesterol sulfate. In the present study, we have measured STS mRNA levels in 97 breast cancers by reverse transcription-PCR using a fluorescent primer in the presence of an internal standard RNA ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Utsumi T,Yoshimura N,Takeuchi S,Ando J,Maruta M,Maeda K,Harada N

    更新日期:1999-01-15 00:00:00

  • Oxidoreductase activities in normal rat liver, tumor-bearing rat liver, and hepatoma HC-252.

    abstract::Experiments were carried out to determine if the difference in rates of cell proliferation between normal and neoplastic cells may be related to altered levels of oxidative enzymes. Assays were performed using homogenates from hepatocellular carcinoma HC-252, a rapidly growing and moderately well-differentiated tumor;...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Sun AS,Cederbaum AI

    更新日期:1980-12-01 00:00:00

  • Gene transfer of thromboxane A(2) synthase and prostaglandin I(2) synthase antithetically altered tumor angiogenesis and tumor growth.

    abstract::Cyclooxygenase, involved in tumor growth and angiogenesis, converts arachidonic acid to prostaglandin (PG)H(2), which is immediately converted to bioactive prostanoids including PGE(2), PGD(2), thromboxane (TX)A(2) and PGI(2). To test the hypothesis that changes in the prostanoid profile alter cancer growth, we transd...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Pradono P,Tazawa R,Maemondo M,Tanaka M,Usui K,Saijo Y,Hagiwara K,Nukiwa T

    更新日期:2002-01-01 00:00:00

  • Phase I trial of spiromustine (NSC 172112) and evaluation of toxicity and schedule in a murine model.

    abstract::Phase I evaluation of spiromustine was performed using an every-3-week schedule and a weekly X 3 schedule. Neurotoxicity was the dose-limiting toxicity presenting as alterations in cortical integrative functions (orientation, language, coordination), leading to a decrease in the level of consciousness. Traditional cri...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Pazdur R,Redman BG,Corbett T,Phillips M,Baker LH

    更新日期:1987-08-01 00:00:00

  • Mitochondrial miRNA Determines Chemoresistance by Reprogramming Metabolism and Regulating Mitochondrial Transcription.

    abstract::miRNAs that translocate from the nucleus to mitochondria are referred to as mitochondrial microRNAs (mitomiR). mitomiRs have been shown to modulate the translational activity of the mitochondrial genome, yet their role in mitochondrial DNA (mtDNA) transcription remains to be determined. Here we report that the mitomiR...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-18-2505

    authors: Fan S,Tian T,Chen W,Lv X,Lei X,Zhang H,Sun S,Cai L,Pan G,He L,Ou Z,Lin X,Wang X,Perez MF,Tu Z,Ferrone S,Tannous BA,Li J

    更新日期:2019-03-15 00:00:00

  • RAE1 ligands for the NKG2D receptor are regulated by STING-dependent DNA sensor pathways in lymphoma.

    abstract::The immunoreceptor NKG2D originally identified in natural killer (NK) cells recognizes ligands that are upregulated on tumor cells. Expression of NKG2D ligands (NKG2DL) is induced by the DNA damage response (DDR), which is often activated constitutively in cancer cells, revealing them to NK cells as a mechanism of imm...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-13-1703

    authors: Lam AR,Bert NL,Ho SS,Shen YJ,Tang LF,Xiong GM,Croxford JL,Koo CX,Ishii KJ,Akira S,Raulet DH,Gasser S

    更新日期:2014-04-15 00:00:00

  • Effect of tamoxifen on the multidrug-resistant phenotype in human breast cancer cells: isobologram, drug accumulation, and M(r) 170,000 glycoprotein (gp170) binding studies.

    abstract::We have performed isobologram analyses of the ability of tamoxifen (TAM) to alter the response to Adriamycin (ADR) and vinblastine (VBL) in human breast cancer cells. MCF-7 cells express functional receptors for estrogen and progesterone but do not express detectable levels of M(r) 170,000 glycoprotein (gp170). CL 10....

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Leonessa F,Jacobson M,Boyle B,Lippman J,McGarvey M,Clarke R

    更新日期:1994-01-15 00:00:00

  • Decreased activation of carcinogens in the liver of carcinogen-resistant rats.

    abstract::We have developed a new strain of rats (resistant rat) which exhibit resistance against the carcinogenic action of several carcinogenic compounds. In the present study, we compared the ability of resistant rat liver to activate 3'-methyl-4-dimethylaminoazobenzene and 2-acetylaminofluorene to highly reactive metabolite...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Yano M,Higashi T,Kano S,Tateishi N,Kido Y,Mori T,Higashi K,Sakamoto Y

    更新日期:1989-10-01 00:00:00

  • Detection of somatic mutations at the glycophorin A locus in erythrocytes of atomic bomb survivors using a single beam flow sorter.

    abstract::A modified method was developed for measuring the frequency of variant erythrocytes at the glycophorin A locus using a single beam cell sorter (SBS). Fluorescein- or phycoerythrin-labeled monoclonal antibodies specific for the M or N glycophorin A alleles were used for the SBS assay. To prevent contamination of nuclea...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Kyoizumi S,Nakamura N,Hakoda M,Awa AA,Bean MA,Jensen RH,Akiyama M

    更新日期:1989-02-01 00:00:00

  • Potentiation of nitrogen mustard cytotoxicity by disulfiram, diethyldithiocarbamic acid, and diethylamine in mice.

    abstract::Disulfiram (DSF) and its metabolites, diethyldithiocarbamic acid (DDC) and diethylamine (DEA), were studied as pretreatments in combination with the alkylating agent nitrogen mustard (HN2) on the cytotoxicity of HN2 against both leukemia cells and normal hematopoietic stem cells. Both time intervals and dose relations...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Valeriote F,Grates HE

    更新日期:1989-12-01 00:00:00

  • Identification of a tumor-suppressive human-specific microRNA within the FHIT tumor-suppressor gene.

    abstract::Loss or attenuated expression of the tumor-suppressor gene FHIT is associated paradoxically with poor progression of human tumors. Fhit promotes apoptosis and regulates reactive oxygen species; however, the mechanism by which Fhit inhibits tumor growth in animals remains unclear. In this study, we used a multidiscipli...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-13-3279

    authors: Hu B,Ying X,Wang J,Piriyapongsa J,Jordan IK,Sheng J,Yu F,Zhao P,Li Y,Wang H,Ng WL,Hu S,Wang X,Wang C,Zheng X,Li W,Curran WJ,Wang Y

    更新日期:2014-04-15 00:00:00

  • β-catenin contributes to lung tumor development induced by EGFR mutations.

    abstract::The discovery of somatic mutations in EGFR and development of EGFR tyrosine kinase inhibitors (TKI) have revolutionized treatment for lung cancer. However, resistance to TKIs emerges in almost all patients and currently no effective treatment is available. Here, we show that β-catenin is essential for development of E...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-14-0184

    authors: Nakayama S,Sng N,Carretero J,Welner R,Hayashi Y,Yamamoto M,Tan AJ,Yamaguchi N,Yasuda H,Li D,Soejima K,Soo RA,Costa DB,Wong KK,Kobayashi SS

    更新日期:2014-10-15 00:00:00